Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA margin is 28.85%.
Reported quarterly EBITDA margin; no daily interpolation.
Limited quarterly history available
EBITDA Margin needs at least three reported quarters before a meaningful chart is shown.
EBITDA MARGIN
28.85%
EBITDA MARGIN AVG TTM
N/A
EBITDA MARGIN AVG 3Y
N/A
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Black Diamond Therapeutics, Inc.
Market Cap
$111.17M
EBITDA Margin
28.85%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$109.49M
EBITDA Margin
-10.96%
TTM Avg
-24.45%
3Y Avg
-32.87%
5Y Avg
-38.11%
Market Cap
$113.77M
EBITDA Margin
-254.71%
TTM Avg
-369.64%
3Y Avg
-290.17%
5Y Avg
-290.17%
Market Cap
$108.39M
EBITDA Margin
-6164.17%
TTM Avg
-4620.17%
3Y Avg
-2654.54%
5Y Avg
-2163.85%
Market Cap
$114.24M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$106.23M
EBITDA Margin
5.60%
TTM Avg
2.28%
3Y Avg
0.00%
5Y Avg
-2.15%
Market Cap
$116.59M
EBITDA Margin
-408000.00%
TTM Avg
-396456.25%
3Y Avg
-201636.71%
5Y Avg
-201636.71%
Market Cap
$117.43M
EBITDA Margin
-254.86%
TTM Avg
-347.69%
3Y Avg
-398.28%
5Y Avg
-4102.41%
Market Cap
$118.02M
EBITDA Margin
-1187.82%
TTM Avg
-1407.84%
3Y Avg
-970.99%
5Y Avg
-809.42%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | $111.17M | 28.85% | N/A | N/A | N/A |
| Apyx Medical Corporation (APYX)vs › | $109.49M | -10.96% | -24.45% | -32.87% | -38.11% |
| Coya Therapeutics, Inc. (COYA)vs › | $113.77M | -254.71% | -369.64% | -290.17% | -290.17% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $108.39M | -6164.17% | -4620.17% | -2654.54% | -2163.85% |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $114.24M | N/A | N/A | N/A | N/A |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $106.23M | 5.60% | 2.28% | 0.00% | -2.15% |
| Genelux Corporation (GNLX)vs › | $116.59M | -408000.00% | -396456.25% | -201636.71% | -201636.71% |
| Foghorn Therapeutics Inc. (FHTX)vs › | $117.43M | -254.86% | -347.69% | -398.28% | -4102.41% |
| Caribou Biosciences, Inc. (CRBU)vs › | $118.02M | -1187.82% | -1407.84% | -970.99% | -809.42% |
| Definitive Healthcare Corp. (DH)vs › | $104.07M | 6.31% | -127.53% | -89.97% | -50.55% |
Gross Margin
99.5%
EBITDA Margin
28.9%
Operating Margin
28.4%
Net Margin
31.9%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2025-03-31 | 78.02% |
